Clinical Trials Browser

Phase 2 × Lung Diseases, Interstitial × pembrolizumab × Clear all

NCT07420439 2026-02-19

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

Phase 2 Not yet recruiting

Lung Diseases, Interstitial